CellSeed develops regenerative-medicine treatments based on cell sheets, thin layers of cultured human cells applied to damaged tissue. Its pipeline centers on autologous and allogeneic cartilage cell sheets. The company sells temperature-responsive culture vessels such as UpCell and RepCell, which release cultured cells as an intact sheet when the temperature is lowered to 20°C.
Its regenerative-medicine services cover process development and contract manufacturing (CDMO) of regenerative products, contract manufacturing of specified processed cells with consulting, and training for cell-culture technicians. The company is based in Aomi, Koto, Tokyo.
0
open positions at CellSeed
No live listings from CellSeed right now — browse all Tokyo software jobs instead.